Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-01-06 @ 4:28 PM
Study NCT ID:
NCT00673569
Status:
COMPLETED
Last Update Posted:
2010-08-09
First Post:
2008-05-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
JHOC-J0655, CDR0000512886
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Charles M. Rudin
Old Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |